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The wild type copia gag precursor protein of Drosophila melanogaster expressed in E. 
coli was shown to be processed autocatalytically to generate two daughter proteins with 
molecular masses of 33 and 23 kD as examined by SDS-PAGE. The active site motif of 
aspartic proteinases, Asp-Ser-Gly, was present in the 23 kD protein corresponding to 
the C-terminal half of the precursor protein. The coding region of this daughter protein 
(152 residues) in the copia gag gene was expressed in E. coli to produce the 
recombinant enzyme protein as inclusion bodies, which was then purified and refolded 
to the active enzyme. Using the peptide substrate 
His-Gly-Ile-Ala-Phe-Met-Val-Lys-Glu-Val-Asn (cleavage site: Phe-Met) designed 
based on the sequence of the cleavage site region of the precursor protein, enzymatic 
properties of the proteinase were investigated. The optimum pH and temperature of the 
proteinase toward the synthetic peptide were 4.0 and 70 oC, respectively. The 
proteolytic activity was increased with increasing NaCl concentration in the reaction 
mixture, the optimum concentration being 2M. Pepstatin A strongly inhibited the 
enzyme with a Ki value of 15 nM at pH 4.0. On the other hand, the active site residue 
mutant, in which the putative catalytic aspartic acid was mutated to an alanine, had no 
activity. These results show that the copia proteinase belongs to the family of aspartic 
proteinases including HIV proteinase. The B chain of oxidized bovine insulin was 
hydrolyzed at the Leu15-Tyr16 bond fairly selectively. Thus, the recombinant copia 
proteinase partially resembles HIV proteinase, but is significantly different from it in 
certain aspects.   
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The retroviral proteinases (retropepsins), including HIV proteinase, share the common 
conserved active site motif Asp-Ser/Thr-Gly with the ordinary aspartic proteinases [1]. 
The same amino acid sequence, Asp-Ser-Gly, was also reported to be present in several 
retrovirus-like transposon elements, such as the Drosophila copia-like element and 
yeast transposon Ty1 [2]. Similarities in sequence organization were also recognized 
between the copia-like element and the aspartic proteinase precursors of vertebrate 
retroviruses [3-6]. Virus-like particles (VLP) were identified from the Drosophila 
melanogaster cell culture [7]. On the other hand, a 2 kb copia RNA was reported to 
contains sufficient information to make the VLP, probably through autoprocessing of 
the copia gag precursor, in Drosophila cultured cells [8]. Furthermore, the precursor 
protein expressed in E. coli was reported to be correctly processed to generate a unique 
laminate structure, indicating involvement of a proteinae in cleaving the gag precursor 
itself [9]. So far, however, the proteinase responsible for the processing and release of 
the VLP protein has not been purified and characterized.  
In this study, the 50 kD copia gag precursor protein expressed in E. coli was shown 
to be processed autocatalytically to give a proteinase-like protein identified on 
SDS-PAGE, and the processing site in the protein was determined by NH2-terminal 
amino acid sequencing. In order to isolate and characterize the proteinase-like protein, 
its coding region was expressed in E. coli, and the recombinant protein was purified 
from the inclusion bodies and refolded to the active enzyme (called copia proteinase in 
this study; MEROPS name: copia transposon (Drosophila type) peptidase; MEROPS 
classification: peptidase A11.001). Enzymatic properties of the recombinant proteinase 
were partially similar to those of retroviral aspartic proteinases, but significantly 
different from them in certain aspects. To our knowledge, this is the first time that a 





Restriction nucleases, T4 polynucleotide kinase and T4 DNA ligase were purchased 
from TOYOBO. The Nco1 linker (5’- CAGCCATGGCTG-3’), the expression vector 
pKK233-2, E. coli JM 109 and Sephacryl S-200 were obtained from Pharmacia. DEAE 
cellulose (DE-52) was obtained from Whatman and polyvinylidene difluoride 
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membrane from Millipore. A synthetic peptide, 
His-Gly-Ile-Ala-Phe-Met-Val-Lys-Glu-Val-Asn, containing the sequence at the putative 
processing site (Met274-Val275) of the 50 kD precursor protein was synthesized by using 
Applied Biosystems peptide synthesizer model 431 A and purified by HPLC. Its purity 
and sequence was confirmed by amino acid sequencing. 
 
Plasmid construction and expression 
To express the entire open reading frame (ORF) of the 2 kb RNA (termed ORF2) in E. 
coli, the plasmid pEC1 [9] was used as a starting material. To express the enzyme 
protein, the dinucleotide sequence (TpT) near the first methionine codon in the 
processing site (Met274-Val275) of ORF2 was converted to CpC using oligonucleotide 
GCATTGCGTCCATGGTAAAA in order to create a NcoI site. The HpaI site located in 
the downstream of ORF 2 was changed using the NcoI linker. The resulting 0.57 kb 
NcoI fragment (which covers the proteinase region of ORF2) was inserted into the NcoI 
site of the expression vector pKK233-2 to obtain the plasmid pEC3. Plasmid pEC16 
was constructed in the same manner as pEC3 except for the site which harbors the 
GAT-GCT mutation responsible for the Asp→Ala mutation at the putative active site 
motif (Asp-Ser-Gly). 
  E. coli containing each expression plasmid was grown in L-broth at 37 oC until the 
mid log phase (OD600= 0.5 - 0.7), then gene expression was induced by the addition of 
isopropyl-β-D-thiogalactoside to a final concentration of 50 µg/ml. The bacteria were 
further grown at 37 oC for 6 - 8 h unless otherwise specified and the cells were collected 
and stored at – 80 oC. 
 
Production of antibodies against the enzyme protein 
The recombinant enzyme protein was eluted from the SDS-PAGE gels of the extract of 
E. coli cells with pEC1 plasmid by electroelution. The purified protein was emulsified 
with Freund’s complete adjuvant and injected intradermally into two rabbits. After four 
weeks rabbits were boosted with the protein several times until a satisfactory antibody 
titer was obtained as judged by Western blot analysis. 
 
Western blotting 
Samples were submitted to SDS-PAGE on 12% acrylamide gels [10] and electroblotted 
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onto polyvinylidene difluoride membrane. Protein bands were stained using a 
VECTASTAIN ABC immunochemical staining kit (Vector Laboratories, Burlingame, 
CA, U.S.A.). 
 
Amino acid sequence analysis 
Proteins in the SDS-PAGE gel were electroblotted onto polyvinylidene difluoride 
membrane with 10 mM 3-(cyclohexylamino)-1-propanesulphonic acid buffer, pH 11, 
and the membrane was stained with Coomassie Brilliant Blue R-250. Protein bands 
corresponding to 50, 33 and 23 kD were cut out and submitted to sequencing using 
Applied Biosystems pulse-liquid protein sequencer model 477/120A. 
  
Isolation and purification of the enzyme protein  
Bacterial cells from 4 litre culture were suspended in 280 ml of 50 mM Tris-HCl , pH 
8.0, containing 1 mM EDTA, 1 mM PMSF, and 1 mg/ml lysozyme. It was incubated for 
15 min at 25 oC, and placed on ice for 10 min. Cells were disrupted by sonication with 
three 20 sec bursts at 4 oC and the resulting cell lysate was centrifuged at 3000 g. The 
pellet containing inclusion bodies was suspended in 560 ml of 50mM Tris-HCl, pH 8.0, 
containing 1mM EDTA, 1mM PMSF, 100 mM NaCl and 0.5 % Triton X-100. The 
resulting suspension was centrifuged at 30000 g for 30 min and the pellet was 
resuspended in 280 ml of 0.1 M Tris-HCl buffer, pH 8.5, containing 1 mM EDTA, 
1mM PMSF and 2 M urea. The suspension was centrifuged at 30000 g for 30 min to 
collect the pellet. The pellet was dissolved in 200 ml of 0.5 M Tris-HCl, pH 8.0, 1 mM 
EDTA, 1 mM PMSF and 6 M urea by homogenization. The resulting homogenate was 
centrifuged at 30000 g for 30 min and the clear supernatant was dialysed against 5 liters 
of buffer A (20 mM MOPS, pH 8.0, 1 mM EDTA, 1 mM PMSF, 30 mM 
2-mercaptoethanol and 6 M urea). 
  The dialyzed supernatant was applied to a DEAE-cellulose column (2.8 x 32 cm) 
equilibrated with buffer A and the column was washed with 2 litres of the same buffer. 
Protein was eluted with a linear gradient of 0 - 0.75M NaCl in a total volume of 1 litre 
of buffer A. Fractions with absorbance at 280 nm were subjected to SDS-PAGE and 
those with the 23 kD protein were identified by Western blotting followed by 
immunochemical staining. The fractions containing the 23 kD protein were pooled, 
dialysed against 4 litres of buffer A and concentrated by using a small DEAE-cellulose 
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(DE-52) column (1.0 x 1.0 cm). A 10-ml aliquot of the concentrated sample was 
gel-filtered on a Sephacryl S-200 column (3.1 x 145 cm) equilibrated with buffer A 
containing 0.2 M NaCl. Fractions were analysed by SDS-PAGE followed by Western 
blot analysis and the major fractions containing the 23 kD protein were pooled and 
stored at 4oC.  
  A 10-ml aliquot of the above pooled Sephacryl S-200 fraction was diluted with buffer 
A to a final protein concentration of 0.08 mg/ml and dialysed against 1 litre of 50 mM 
sodium acetate buffer, pH 5.5, containing 10% glycerol, 5% ethylene glycol, 0.02% 
Nonidet p40, 1 mM EDTA and 30 mM 2-mercaptoethanol at 4 oC for 24 h. The dialysed 
sample was centrifuged at 100000 g and 4 oC for 60 min. The resulting supernatant was 
further dialysed successively against 1 litre each of 50 mM sodium acetate buffer, pH 
5.5, containing 30, 20 and 10 mM 2-mercaptoethanol and centrifuged at 100000 g for 
120 min. The dialysed sample was gel-filtered on a Tosoh TSKgel G3000 SW column 
(0.75 x 60 cm) equilibrated with 50 mM sodium acetate buffer, pH 5.5. Each fraction 
was analysed by SDS-PAGE and immuno-blotting using the antiserum against the 23 
kD protein.  
 
Determination of proteolytic activity  
Unless otherwise specified, 50 µl of 1 mM synthetic peptide in 0.05 M sodium acetate 
buffer, pH 5.5, containing 1 mM dithiothreitol (DTT) and 0.2 M NaCl was mixed with 
10 µl of the refolded proteinase solution and incubated at 37 oC for 30 min. The reaction 
was terminated by the addition of 240 µl of 5% trifluoroacetic acid and freezing. The 
reaction products were analyzed by HPLC using an ODS-032 (ABI) column with a 
linear gradient of 0 - 52.5% acetonitrile in 20 min at a flow rate of 1 ml/min. 
Absorbance of the effluent was monitored at 215 nm and the cleavage products were 
identified by amino acid analysis and sequencing. 
  The pH dependence of activity was analyzed as follows. 120 µl of 1 mM synthetic 
peptide in 20 mM formate, 20 mM acetate, 10 mM methanesulfonate or 40 mM Tris 
buffer at different pH values containing 1mM DTT were incubated with 0.4 µg of the 
refolded proteinase at 37 oC for 30 min. The reaction was stopped by the addition of 480 
µl of 5% trifluoroacetic acid and the extent of peptide cleavage was analysed by HPLC 
as described above The temperature dependence of activity was analysed in the same 
manner except that the assay was performed in 50 mM sodium acetate buffer, pH 4.0, (1 
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mM DTT) at various temperatures. The effect of NaCl concentration on activity was 
analyzed in the same manner except that the assay was performed in 200 mM sodium 
acetate buffer, pH 4.0, (1 mM DTT) at 37 oC at various concentrations of NaCl (0 - 5 
M). The effects of various inhibitors on activity were analysed in the same manner 
except that the assay was performed in 100 mM sodium acetate buffer, pH 4.0, (1 mM 
DTT, 0.2 M NaCl) at 37 oC in the presence of each inhibitor after preincubation at 37 oC 
for 30 min. 
  The activity toward hemoglobin was determined as described [11]. 
 
Measurements of stability of the proteinase 
To measure the thermal stability, 1 µg of the recombinant proteinase in 50 µl of 0.1 M 
sodium acetate buffer, pH 4.0, (1 mM DTT) was incubated at different temperatures for 
1 h and the remaining activity was determined under the standard assay conditions. To 
measure the stability at pH 7.4, about 15 µg of the proteinase in 1.5 ml of 0.05 M 
Tris-HCl, pH 7.4, 1 mM DTT was incubated at 37 oC. Aliquots were withdrawn at 
different time intervals and the remaining activity was determined under the standard 
assay conditions. 
 
Reaction of diazoacetyl-D,L-norleucine methyl ester (DAN) with the proteinase 
The proteinase (8 µg) was incubated with 50 µg of DAN in 0.8 ml of 0.05 M sodium 
phosphate buffer, pH 6.0, at 25 oC in the presence and absence of 1 mM cupric sulfate. 
Aliquots were removed at appropriate intervals and the remaining activity was 
determined. 
 
Analysis of the cleavage specificity of the proteinase toward the B chain of oxidized 
insulin 
The B chain of oxidized insulin (100 nmol) was digested with 8 µg of the proteinase in 
300 µl of 0.05 M sodium acetate buffer, pH 4.0, containing 1 mM DTT and 0.2 M NaCl. 
Aliquots of 100 µl were removed at appropriate time intervals and submitted to HPLC 
using a Hitachi 655A-11 system on a column (0.46 x 25 cm) of TSKgel ODS-120T 
(Tosoh Co.). The peptides were eluted with a linear gradient of acetonitrile (0 to 50%) 
in 30 min in 0.1% trifluoroacetic acid at a flow rate of 0.8 ml/min. The effluent was 
monitored by measuring the absorbance at 215 nm and the peptide peak fractions were 
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collected and lyophilized. An aliquot of each peptide fraction dissolved in water was 





Identification of the proteolytic processing site in the copia gag precursor protein 
During the cultivation of E. coli containing the pEC1 plasmid, the intensities of three 
protein bands (bands I, II and III) were shown to increase as analysed by SDS-PAGE, 
corresponding to apparent molecular masses of 50, 33 and 23 kD, respectively (Fig. 1a). 
The band I and II proteins were stained with an anti-VLP antiserum, whereas the band 
III protein was not (Fig. 1b). This indicated that the 50 kD gag precursor protein was 
expressed and then processed into the 33 and 23 kD daughter proteins.  
  The NH2-terminal amino acid sequences of these proteins were determined as shown 
below. 
 
Band I protein: Met-Asp-Lys-Ala-Lys-Arg-Asn-Ile-Lys-Pro-  
Band II protein: Met-Asp-Lys-Ala-Lys-Arg-Asn-Ile-Lys-Pro- 
Band III protein: Val-Lys-Glu-Val-Asn-Asn-Thr-Ser-Val-Met-Asp-Asn-Cys-Gly-Phe- 
 
The NH2-terminal sequences of the band I and II proteins were the same, which were 
identical with that deduced from the DNA sequence of the gag precursor. On the other 
hand, the NH2-terminal 15-residue sequence of the band III protein was identical with 
the sequence from Val 275 to Phe 289 of the deduced sequence of the precursor gag 
protein. These results confirmed that the band II and III proteins were produced from 
the expressed band I precursor gag protein, through cleavage at the Met274-Val 275 bond. 
The putative active site motif of aspartic proteinases, Asp-Ser-Gly, was present in the 
band III protein and an antiserum raised against this protein reacted with the band I 
precursor protein, but not with the band II protein. These findings suggest that the band 
III protein may be a proteinase and responsible for the observed processing of the gag 
precursor protein. The soluble fraction of a crude extract of E. coli cells harbouring the 
pEC1 plasmid, however, showed no significant activity toward the synthetic peptide 
substrate.  
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Expression, isolation, and purification of the enzyme protein  
The region coding for the band III protein was obtained from the copia pZY2 (8) and 
inserted into the pKK233-2, and the resulting pEC3 plasmid was expressed in E. coli. 
The increase in intensity of the corresponding protein band was observed with the 
isopropyl-β-D-thiogalactoside induction up to 8 h (Fig. 1c) and only this band reacted 
with the antiserum raised against the band III protein (Fig. 1d). The protein expressed in 
1 litre of the E. coli cell culture was around 25 mg at 8 h after the induction as estimated 
by SDS-PAGE. 
  Ninety percent of the enzyme protein present in the purified inclusion body pellet was 
solubilized in the buffer containing 6 - 8 M urea and 30 mM 2-mercaptoethanol. The 
enzyme protein was purified by successive steps of chromatography on DEAE-cellulose 
and Sephacryl S-200 gel filtration (Figs. 2a and 2b). The purity of the fractions was 
analyzed by SDS-PAGE. Fractions 54 to 60 in Sephacryl S-200 gel filtration were the 
major fractions containing the enzyme protein (Fig. 2d). Thus, about 25 mg of the 
purified protein was obtained from 100 mg of the expressed protein in 4 litres of the E. 
coli cell culture.  
The enzyme protein was then refolded to the proper conformation with proteolytic 
activity by gradually removing urea (from 6 M to 0 M) followed by stepwise removal of 
2-mercaptoethanol (from 30 to 20 mM and then from 20 to 10 mM). After refolding, the 
insoluble unfolded protein was removed by centrifugation at 100000 g for 1 h, and the 
refolded proteinase was purified by gel filtration on a TSKgel G3000SW column (Fig. 
2c). The purified refolded enzyme gave a single band on SDS-PAGE (Fig. 2e). Its 
molecular mass was estimated to be 23 kD by SDS-PAGE under both reducing and 
non-reducing conditions and by gel filtration (data not shown). 
 
Development of an assay procedure to characterize the copia proteinase 
A synthetic 11-residue peptide, His-Gly-Ile-Ala-Phe-Met-Val-Lys-Glu-Val-Asn, 
corresponding to the sequence at the processing site and its vicinity of the gag precursor 
protein was synthesized and used as the substrate. A typical HPLC analysis of the 
reaction mixture is shown in Figs. 3a and 3b; the peak height of the intact peptide was 
decreased with time and two new peaks appeared. They were identified to be 
His-Gly-Ile-Ala-Phe and Met-Val-Lys-Glu-Val-Asn by amino acid sequencing. The 
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increases in height of these peaks were linear up to 60 min (Fig. 3c) at a saturating 
substrate concentration (around 1 mM) (Fig. 4a). Therefore, a 30 - 60 min incubation 
period was used to determine the activity of the proteinase. 
 
Enzymatic properties of the proteinase 
The Km and Vmax values of the proteinase toward the synthetic peptide at pH 5.5 and 
37 oC were estimated to be 235 µM and 81.3 pmol ‧min-1 ‧µg-1, respectively, by  
using Lineweaver-Burk plot (Fig. 4b). The pH and temperature dependences of 
proteolytic activity of the enzyme are shown in Figs. 5a and 5b, respectively. The 
optimum pH of the activity toward the synthetic peptide was 4.0 (Fig. 5a) and the 
specific activity at the optimum pH was determined to be 144 pmol ‧min-1 ‧µg-1.  
Therefore the activity of the enzyme was assayed at pH 4.0 in the subsequent studies 
unless otherwise specified.  On the other hand, the optimum activity toward 
acid-denatured hemoglobin was observed at pH 2.0 (Fig. 5a). When the assay 
temperature was elevated, the activity of the enzyme increased up to 70 oC and a sharp 
decline was observed beyond 70 oC (Fig. 5b). The activity at 37 oC was 69% of that 
observed at the optimum temperature, 70 oC.  
The stability of the enzyme at different temperatures and pH 4.0 and that at pH 7.4 
and 37 oC are also shown in Fig. 5. The enzyme was stable up to 50 oC at pH 4.0 and a 
gradual decrease of activity was observed above 50 oC; the enzyme was completely 
inactivated after one hour incubation at 85 oC (Fig. 5b). The enzyme was not very stable 
at pH 7.4 and 37oC and a gradual reduction of activity was observed with incubation 
time. The half-life was 24 h, and complete inactivation was observed after 48 h (Fig. 
5c). 
When NaCl was added to the assay mixture, a gradual increase of activity was 
observed up to 2 M NaCl; the activity was decreased gradually above 2 M NaCl (Fig. 
5d). Pepstatin A strongly inhibited the enzyme; a Ki value of 15 nM was obtained at pH 
4.0 by using Dixon plots (Fig. 4c).  DAN was shown to inactivate the enzyme to a 
significant extent in the presence of cupric ions (Fig. 4d). Under the reaction conditions 
used in the presence of 1 mM Cu2+, the activity was lost by 50% in 2 h and decreased 
further upon longer incubation.  In the absence of cupric ions, no significant 
inactivation took place. On the other hand, no inhibition was observed with any of the 
following inhibitors for serine, cysteine, or metallo-peptidases or aminopeptidases at the 
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given concentrations: diisopropylfluorophosphate (0.1 mM), PMSF (1 mM), 
tosyl-L-phenylalanine chloromethyl ketone (1 mM), 
1-trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (0.1 mM), o-phenanthroline 
(10 mM), EDTA (10 mM), soybean trypsin inhibitor (0.1 µg/ml), leupeptin (0.1 mM), 
antipain (0.1 mM), amastatin (0.1 mM) and diprotinin A (0.05 mM).  
  The cleavage profile of the enzyme toward the B chain of oxidized insulin at pH 4.0 
is shown in Fig. 6. The Leu15-Tyr16 bond was cleaved fairly selectively, followed by 
slower cleavages at the Tyr16-Leu17, Glu13-Ala14, Glu21-Arg22, and Phe25-Tyr26 in a 
decreasing order. 
 
Loss of the proteolytic activity by active site residue mutation 
The mutant enzyme in which the putative catalytic residue Asp18 was changed to Ala 
was expressed in E. coli cells containing the pEC16 plasmid, purified and refolded by 
essentially the same procedures as used for the wild type enzyme. The expression yield 
and the elution profiles on chromatography of the mutant protein were practically the 
same as those of the wild type proteinase. The refolded mutant protein, however, 
showed no activity toward the synthetic peptide.  
 
DISCUSSION 
As described in the preceding section, when the 2 kb copia RNA was expressed in E. 
coli containing the plasmid pEC1, a protein with an apparent molecular mass of 23 kD 
was shown to be produced, in addition to the 50 kD gag precursor protein and the 33 kD 
VLP protein, which had previously been found by Yoshioka et al. [9]. The 
NH2-terminal amino acid sequencing of these proteins clearly showed the processing of 
the 50 kD precursor protein to produce the two daughter proteins, which represent the 
NH2- and COOH-terminal halves, respectively, of the 50 kD protein.  
  Attempts to demonstrate the activity of the copia proteinase in the lysate of E. coli 
cells with the plasmid pEC1 toward the synthetic peptide or toward the 50 kD precursor 
protein obtained from E. coli containing the pEC2 plasmid were not successful, 
presumably due to a very low concentration of the active proteinase in the E. coli cell 
lysate. Thus, direct purification of the enzyme protein from E. coli cells with the 
plasmid pEC1 was difficult; therefore, the coding region of the enzyme protein in the 
copia gag gene was expressed in E. coli to obtain a high level of expression. 
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The simple purification and refolding procedures permitted us to obtain as much as 
6.3 mg of the active proteinase from 1 litre of the E. coli culture. A selective cleavage of 
the synthetic peptide (His-Gly-Ile-Ala-Phe-Met-Val-Lys-Glu-Val-Asn) was observed at 
the Phe5-Met6 bond by the purified proteinase. On the other hand, the NH2-terminal 
amino acid sequence of the enzyme protein from E. coli cells containing the plasmid 
pEC1 started from Val275 in the sequence -Phe273-Met274-Val275-. These results suggest 
that the initial processing site in the 50 kD gag precursor protein is the Phe273-Met274 
bond and that the resulting NH2-terminal Met274 residue was removed presumably by the 
action of methionyl aminopeptidase present in E. coli. Similarly, the removal of the 
NH2-terminal Met residue from the enzyme protein obtained from E. coli cells 
containing the plasmid pEC3 was also observed. The Met residues in the NH2-terminal 
Met-Asp- sequence of the 50 and 33 kD proteins were not removed. It is known that 
when the next residue has a side chain with a low radius of gyration (Gly, Ala, Ser, Thr, 
Pro, Val or Cys), the NH2-terminal methionine is removed by methionyl aminopeptidase, 
but otherwise it is retained [12]. The above results are consisitent with this specificity of 
methionyl aminopeptidase. 
The ordinary aspartic proteinases are composed of two lobes highly homologous in 
tertiary structure [1]. Each lobe is composed of a single polypeptide chain of more than 
150 residues with a conserved Asp-Thr/Ser-Gly motif constituting the active site of the 
enzyme. In contrast, retroviral proteinases are generally composed of two identical 
subunits, and each subunit is composed of less than 130 amino acids and contains only 
one Asp-Thr/Ser-Gly motif. In the case of HIV proteinase, its subunit was first 
demonstrated to dimerize to form the active enzyme [13]. Therefore, in analogy to HIV 
proteinase and other retroviral proteinases, dimerization of the present enzyme protein is 
thought to be the prerequisite to exhibit proteolytic activity. The actual molecular mass 
of the proteinase based on its amino acid sequence of 152 residues is 16.7 kD. On the 
other hand, the active proteinase was eluted at the position of 23 kD on gel filtration. 
This seems to indicate dimerization of the protein. However, the proteinase was also 
observed at the 23 kD region on SDS-PAGE under both reducing and non-reducing 
conditions. This is presumably due to an anomalous behavior of the proteinase subunit 
on SDS-PAGE to give an apparently higher molecular mass than the theoretical one. 
Indeed, certain low molecular weight proteins are known to behave anomalously on 
SDS-PAGE [14]. For examples, ribonuclease A (13.7 kD), ribonuclease T1 (11.1 kD) 
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and the heavy chain of aspergillopepsin (18.3 kD) were reported to give molecular 
masses of 18.5 kD (35% overestimated) [14], 18.0 kD (62% overestimated) [15] and 
33.0 kD (80% overestimated) [16], respectivily, on SDS-PAGE. The molecular mass of 
23 kD estimated by gel filtration is somewhat lower than the theoretical value of 33.4 
kD. The reason for this is not certain at present.  
The present enzyme had a pH optimum at 4.0 toward the synthetic peptide. This is 
roughly similar to the result reported for HIV-1 proteinase, which, however, has a 
broader pH optimum ranging from pH 3.5 to 5.5 toward a synthetic peptide [17]. The 
optimum pH values for other retroviral proteinases were reported to range from pH 5.5 
to 7.2 [18]. Although the present enzyme was shown to act optimally at pH 2.0 toward 
hemoglobin, this is presumably due to more extensive denaturation of the substrate at 
lower pH values.  
The optimum temperature (70 oC at pH 4.0) of the proteinase was remarkably higher 
than that of HIV-1 proteinase (37 oC at pH 6.0), which is inactive above 60 oC [17]. The 
present enzyme was fairly stable up to 50 oC at pH 4.0, and above this temperature it 
became less stable. On the other hand, human pepsin A was reported to be fairly stable 
up to 60 oC at pH 5.5, above which it is inactivated rapidly [11]. Taken together, the 
present enzyme appears to be markedly more stable at higher temperatures than HIV-1 
proteinase. The polypeptide chain of HIV-1 proteinase is composed of 99 amino acid 
residues with the catalytic aspartic acid residue at position 25. On the other hand, that of 
the present enzyme is composed of 152 residues with the putative catalytic aspartic acid 
residue at position 18. Therefore, the present enzyme has a longer COOH-terminal tail 
as compared with HIV-1 proteinase. This tail region might contribute to the stability of 
the present enzyme. The enzyme was not very stable at pH 7.4, but was relatively more 
stable than ordinary aspartic proteinases. For example, human pepsin A is rapidly 
inactivated at pH 7.0 and 37 oC; the half-life is about 1 min and is almost completely 
inactivated within 10 min [11]. The structural basis for this stability of the present 
enzyme remains to be elucidated. 
 The enzyme was inhibited by the two aspartic proteinase-specific inhibitors, 
pepstatin A and DAN. Pepstatin A inhibited the enzyme with a Ki value of 15 nM. On 
the other hand, HIV-1 proteinase was reported to be inhibited by pepstatin A with a Ki 
value of 1.1 µM at pH 5.5 [19] or with an IC50 values of 700 nM at pH 6.0 [20] and 360 
nM at pH 5.5 [21]. The IC50 values for other retrovirus proteinases were reported to be 
Biochemical Journal Immediate Publication. Published on 3 Jul 2006 as manuscript BJ20060800
Copyright 2006 Biochemical Society
 14 
in the range 100 – 500 nM [22]. Therefore, the present enzyme is more sensitive to 
pepstatin A than retrovirus proteinases, although much less sensitive than ordinary 
aspartic proteinases such as porcine pepsin (Ki=0.05 nM at pH 5.0 [23]). The enzyme 
was also inactivated by DAN in the presence of cupric ions although the rate of 
inactivation appeared to be somewhat slower than those of ordinary aspartic proteinases. 
Moreover, the enzyme was not inhibited by any of the proteinase inhibitors tested 
except for pepstatin A and DAN, and the mutant (Asp18→Ala) enzyme had no activity. 
These results are consistent with the notion that the enzyme is a member of the aspartic 
proteinase family. 
The processing site of the gag precursor protein was deduced to be the Phe273-Met274 
bond. On the other hand, the enzyme cleaved most rapidly the Leu15-Tyr16 bond in the B 
chain of oxidized insulin, with slower cleavages at four other peptide bonds, Tyr16-Leu17, 
Glu13-Ala14, Glu21-Arg22, and Phe25-Tyr26 in a decreasing order. Thus, the enzyme 
appears to prefer certain hydrophobic or aromatic or glutamic acid residue at the P1 
position. These results indicate that the specificity of the enzyme is not restricted to the 
peptide bond at the processing site of the copia gag precursor as in the cases of other 
retroviral proteinases [24]. The cleavage specificity toward oxidized insulin B chain is 
fairly different from that of HIV-1 proteinase, which was reported to cleave the 
Glu13-Ala14 bond most rapidly, followed by the Tyr16-Leu17 bond, with slower cleavages 
at the Leu11-Val12 and Leu15-Tyr16 bonds [25]. Since the Leu15-Tyr16 bond is also one of 
the major cleavage sites by several ordinary aspartic proteinases [26], the cleavage 
specificity of the present enzyme toward oxidized insulin B chain is similar, though not 
identical, to those of ordinary aspartic proteinases. 
To shed further light on the structure/function relationship of the present enzyme, it 
would be essential to elucidate its three-dimensional structure. 
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Legends to Figures 
Figure 1  Time course of processing of the wild-type copia gag precursor 
expressed in E. coli with pEC1 (a and b) and that of expression of the 23-kD 
protein (copia proteinase) in E. coli with pEC3 (c and d) as analyzed by 
SDS-PAGE (a and c) and Western blot analysis (b and d). At the indicated times 
after addition of isopropyl-β-D-thiogalactoside, the cells (2 x 107) were lysed in 10 µl of 
the lysiss buffer, and the resulting lysates were submitted to SDS-PAGE and 
immuno-blot analysis using an anti-VLP serum (b) or an anti-serum against the 23-kD 
protein obtained from E. coli with pEC1 (d). Approximate molecular masses are also 
shown for standard marker proteins: phosphorylase B (97.4 kD), bovine serum albumin 
(66.2 kD), ovalbumn (45.0 kD), carbonic anhydrase (31.0 kD), soybean trypsin inhibitor 
(21.5 kD) and lysozyme (14.4 kD). 
 
Figure 2  Isolation and purification of the 23 kD protein (copia proteinase) 
expressed in E. coli with pEC3. (a) DEAE-cellulose chromatography. The solution of 
the solubilized inclusion body from E. coli with pEC3 was applied to a DEAE-cellulose 
column (2.8 x 32 cm) at pH 7.9 and eluted with a linear gradient of 0 to 0.75 M NaCl in 
a total volume of 1 litre. The fraction size was 7.5 ml. (b) Sephacryl G-200 
chromatography. The pooled fraction from the DEAE-cellulose chromatography was 
concentrated and applied to a Sephacryl S-200 column (3 x 145 cm) at pH 7.9. Fraction 
size, 7.5 ml. (c) TSKgel G3000 SW chromatography. The pooled fraction from the 
Sepharcryl S-200 column was submitted to the refolding procedure, and then applied to 
a TSKgel G3000 SW column at pH 5.5. Arrows indicate the elution positions of 
standard proteins: 1, bovine serum albumin; 2, ovalbumin; 3, soybean trypsin inhibitor; 
4, lysozyme. (d) SDS-PAGE of Sephacryl S-200 fractions. (e) SDS-PAGE of the pooled 
TSKgel G3000SW fraction. The same standard marker proteins were used in (d) and (e) 
as used in Fig. 1. In each chromatography the fractions under the bar were pooled. The 
numbers above the gel in SDS-PAGE (d) indicate fraction numbers. 
 
Figure 3  HPLC assay for copia proteinase using the synthetic peptide 
His-Gly-Ile-Ala-Phe-Met-Val-Lys-Glu-Val-Asn as a substrate.  (a) HPLC of the 
intact peptide. (b) HPLC of a 1-h digest of the peptide. (c) Time course of the peptide 
hydrolysis. Peptides are shown in single letter notation. 
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Figure 4  Effects of substrate concentration and inhibitors on the activity of 
colpia proteinase. (a) The initial rates of hydrolysis were measured at various 
concentrations of substrate. (b) Lineweaver-Burk plot of the data in (a). (c) Dixon plot 
for pepstatin inhibition. (d) Time courses of changes in activity by reaction with DAN 
were measured in the presence (●) and absence (○) of 1 mM cupric ions. 
 
Figure 5  Effects of various factors on the activity of copia proteinase. (a) Effect of 
pH on the activity toward the synthetic substrate (●) and hemoglobin (○). (b) Effects 
of temperature on the activity (●) and stability (○). To measure the stability, the 
enzyme was preincubated for 1 h at different temperatures, then assayed at 37oC. (c) 
Effect of incubation at pH 7.0 on the activity. (d) Effect of NaCl concentration on the 
activity. 
 
Figure 6  Cleavage specificity of copia proteinase toward oxidized insulin B chain. 
(a) HPLC pattern of a 3-h digest of oxidized insulin B chain. The number on each peak 
indicates the residue positions of the peptide in the substrate. (b) Yields of peptides and 
sites of cleavage. Arrowheads indicate the cleavage sites and the number under each 
arrowhead shows estimated extent of cleavage in per cent. Bars indicate peptide 
fragments produced and the number in each bar shows the per cent yield of the peptide. 
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